HUTCHMED (China) Ltd
HCM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001648257
No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.
Other share classesHMDCF
Q4 2025 vs. Q3 2025
How the institutions holding HUTCHMED (China) Ltd changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 58 | 50 | −8 |
| Shares | 5.78M | 5.18M | −602.7K (−10.4%) |
| Value | $90.9M | $69.1M | −$21.8M (−24.0%) |
New holders (3)
Institutions that held HUTCHMED (China) Ltd at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pinnacle Wealth Planning Services, Inc. | 124 | $1.65K | 0.00% |
| Eurizon Capital SGR S.p.A. | 27 | $360 | 0.00% |
| Smartleaf Asset Management LLC | 4 | $53 | 0.00% |
Sold out (11)
Institutions that held HUTCHMED (China) Ltd at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| GTS Securities LLC | 82,132 | $1.29M |
| Abn Amro Investment Solutions | 62,277 | $980.9K |
| Tema ETFs LLC | 40,959 | $645.1K |
| Marshall Wace, LLP | 14,897 | $234.6K |
| Vident Advisory, LLC | 10,527 | $165.8K |
| China Universal Asset Management Co., Ltd. | 5,437 | $85.6K |
| Barclays PLC | 2,720 | $42.8K |
| Mirae Asset Global Investments Co., Ltd. | 1,199 | $18.9K |
| GF Fund Management Co. Ltd. | 669 | $10.5K |
| Daiwa Securities Group Inc. | 85 | $1.00K |
| Principal Securities, Inc. | 16 | $252 |